Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels-Reference-Cited by-同舟云学术

Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels

Published:2019-04-15 Issue:4 Volume:79 Page:260-267
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Fabricio Aline S.C.¹^ORCID,Michilin Silvia¹,Zancan Matelda²,Agnolon Valentina¹^ORCID,Peloso Lucia¹,Dittadi Ruggero³^ORCID,Scapinello Antonio⁴,Ceccarelli Claudio⁵^ORCID,Gion Massimo¹^ORCID

Affiliation:

1. Regional Center for Biomarkers, Department of Clinical Pathology and Transfusion Medicine, Azienda ULSS 3 Serenissima, Regional Hospital, Venice, Italy;

2. Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy;

3. Laboratory Analysis Unit, Department of Clinical Pathology and Transfusion Medicine, Dell'Angelo Hospital, Azienda ULSS 3 Serenissima, Mestre-Venice, Italy;

4. Department of Pathology, General Regional Hospital, Azienda ULSS 2 Marca Trevigiana, Castelfranco Veneto, Italy;

5. Department of Specialized, Experimental, and Diagnostic Medicine - DIMES, University of Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy

Funder

Italian Association for Research on Cancer

Special Program Molecular Clinical Oncology

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365513.2019.1600200

Reference44 articles.